Cancer Genetics, Inc. And Mayo Clinic Provide Update On Their Joint Venture To Develop Next Generation Sequencing Company Focused On Areas Of Critical Need In Oncology

RUTHERFORD, N.J., Nov. 22, 2013 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (“CGI” or the “Company”) is jointly hosting an event today with the Mayo Clinic announcing the first projects to be pursued by their joint venture, which is set to develop targeted diagnostic panels that leverage next generation sequencing (“NGS”).

Help employers find you! Check out all the jobs and post your resume.